These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32048561)

  • 1. Anti-inflammatory effects of nobiletin on TLR4/TRIF/IRF3 and TLR9/IRF7 signaling pathways in prostate cancer cells.
    Deveci Ozkan A; Kaleli S; Onen HI; Sarihan M; Guney Eskiler G; Kalayci Yigin A; Akdogan M
    Immunopharmacol Immunotoxicol; 2020 Apr; 42(2):93-100. PubMed ID: 32048561
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of TLR4/TRIF/IRF3 Signaling Pathway by Curcumin in Breast Cancer Cells.
    Güney Eskiler G; Deveci Özkan A; Kaleli S; Bilir C
    J Pharm Pharm Sci; 2019; 22(1):281-291. PubMed ID: 31287789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the Effects of Nobiletin on Toll-Like Receptor 3 Signaling Pathways in Prostate Cancer
    Ozkan AD; Sarihan M; Kaleli S
    Nutr Cancer; 2021; 73(7):1138-1144. PubMed ID: 33121290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melatonin modulates TLR4-mediated inflammatory genes through MyD88- and TRIF-dependent signaling pathways in lipopolysaccharide-stimulated RAW264.7 cells.
    Xia MZ; Liang YL; Wang H; Chen X; Huang YY; Zhang ZH; Chen YH; Zhang C; Zhao M; Xu DX; Song LH
    J Pineal Res; 2012 Nov; 53(4):325-34. PubMed ID: 22537289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin attenuates the TLR4-mediated inflammatory response through MyD88- and TRIF-dependent signaling pathways in an in vivo model of ovarian cancer.
    Chuffa LG; Fioruci-Fontanelli BA; Mendes LO; Ferreira Seiva FR; Martinez M; Fávaro WJ; Domeniconi RF; Pinheiro PF; Delazari Dos Santos L; Martinez FE
    BMC Cancer; 2015 Feb; 15():34. PubMed ID: 25655081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PPARγ agonist rosiglitazone ameliorates LPS-induced inflammation in vascular smooth muscle cells via the TLR4/TRIF/IRF3/IP-10 signaling pathway.
    Ji Y; Liu J; Wang Z; Li Z
    Cytokine; 2011 Sep; 55(3):409-19. PubMed ID: 21700474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-inflammatory action of 2-carbomethoxy-2,3-epoxy-3-prenyl-1,4-naphthoquinone (CMEP-NQ) suppresses both the MyD88-dependent and TRIF-dependent pathways of TLR4 signaling in LPS-stimulated RAW264.7 cells.
    Ju Woo H; Jun DY; Lee JY; Park HS; Woo MH; Park SJ; Kim SC; Yang CH; Kim YH
    J Ethnopharmacol; 2017 Jun; 205():103-115. PubMed ID: 28465253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic glycolipid-based TLR4 antagonists negatively regulate TRIF-dependent TLR4 signalling in human macrophages.
    Palmer C; Facchini FA; Jones RP; Neumann F; Peri F; Pirianov G
    Innate Immun; 2021 Apr; 27(3):275-284. PubMed ID: 33858242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Andrographolide suppresses TRIF-dependent signaling of toll-like receptors by targeting TBK1.
    Kim AY; Shim HJ; Shin HM; Lee YJ; Nam H; Kim SY; Youn HS
    Int Immunopharmacol; 2018 Apr; 57():172-180. PubMed ID: 29518743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RP105 alleviates myocardial ischemia reperfusion injury via inhibiting TLR4/TRIF signaling pathways.
    Yang J; Yang C; Yang J; Ding J; Li X; Yu Q; Guo X; Fan Z; Wang H
    Int J Mol Med; 2018 Jun; 41(6):3287-3295. PubMed ID: 29512709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LPS preconditioning redirects TLR signaling following stroke: TRIF-IRF3 plays a seminal role in mediating tolerance to ischemic injury.
    Vartanian KB; Stevens SL; Marsh BJ; Williams-Karnesky R; Lessov NS; Stenzel-Poore MP
    J Neuroinflammation; 2011 Oct; 8():140. PubMed ID: 21999375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of homodimerization of Toll-like receptor 4 by curcumin.
    Youn HS; Saitoh SI; Miyake K; Hwang DH
    Biochem Pharmacol; 2006 Jun; 72(1):62-9. PubMed ID: 16678799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
    Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
    Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of LPS-mediated inflammation by fenofibrate via the TRIF-dependent TLR4 signaling pathway in vascular smooth muscle cells.
    Ji Y; Wang Z; Li Z; Liu J
    Cell Physiol Biochem; 2010; 25(6):631-40. PubMed ID: 20511708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential outcome of TRIF-mediated signaling in TLR4 and TLR3 induced DC maturation.
    Hu W; Jain A; Gao Y; Dozmorov IM; Mandraju R; Wakeland EK; Pasare C
    Proc Natl Acad Sci U S A; 2015 Nov; 112(45):13994-9. PubMed ID: 26508631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD14 dependence of TLR4 endocytosis and TRIF signaling displays ligand specificity and is dissociable in endotoxin tolerance.
    Rajaiah R; Perkins DJ; Ireland DD; Vogel SN
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8391-6. PubMed ID: 26106158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid Cells Derived from Human Breast Cancer Cells and Human Breast Epithelial Cells Exhibit Differential TLR4 and TLR9 Signaling.
    Tosun S; Fried S; Niggemann B; Zänker KS; Dittmar T
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone deacetylase inhibitor sodium butyrate regulates the activation of toll-like receptor 4/interferon regulatory factor-3 signaling pathways in prostate cancer cells.
    Ozkan AD; Eskiler GG; Kazan N; Turna O
    J Cancer Res Ther; 2023 Oct; 19(7):1812-1817. PubMed ID: 38376283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Adaptor Protein Toll-Like Interleukin Domain Containing Adaptor Inducing Interferon β in Toll-Like Receptor 3- and 4-Mediated Regulation of Hepatic Drug Metabolizing Enzyme and Transporter Genes.
    Shah P; Omoluabi O; Moorthy B; Ghose R
    Drug Metab Dispos; 2016 Jan; 44(1):61-7. PubMed ID: 26470915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TBK1-targeted suppression of TRIF-dependent signaling pathway of toll-like receptor 3 by auranofin.
    Park SJ; Lee AN; Youn HS
    Arch Pharm Res; 2010 Jun; 33(6):939-45. PubMed ID: 20607500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.